EXPONENT INC (EXPO) Stock Price, Quote, News and Overview
NASDAQ:EXPO - Nasdaq - US30214U1025 - Common Stock - Currency: USD
EXPO Quote, Performance and Key Statistics
77.82
-0.86 (-1.09%)
The current stock price of EXPO is 77.82 USD. In the past month the price decreased by -4.81%. In the past year, price decreased by -17.5%.
EXPO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| RELX | RELX PLC - SPON ADR | 38.63 | 99.53B | ||
| TRI | THOMSON REUTERS CORP | 49.14 | 83.66B | ||
| VRSK | VERISK ANALYTICS INC | 44.29 | 41.21B | ||
| EFX | EQUIFAX INC | 35.6 | 32.52B | ||
| LDOS | LEIDOS HOLDINGS INC | 14.35 | 18.80B | ||
| TRU | TRANSUNION | 20.62 | 16.29B | ||
| J | JACOBS SOLUTIONS INC | 18.92 | 15.23B | ||
| BAH | BOOZ ALLEN HAMILTON HOLDINGS | 19.69 | 15.14B | ||
| ULS | UL SOLUTIONS INC - CLASS A | 36.04 | 11.69B | ||
| CACI | CACI INTERNATIONAL INC -CL A | 18.56 | 10.09B | ||
| PSN | PARSONS CORP | 19.07 | 6.82B | ||
| KBR | KBR INC | 15.68 | 6.81B |
Related stock screener links
About EXPO
Company Profile
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. The company is headquartered in Menlo Park, California and currently employs 1,168 full-time employees. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. The company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
Company Info
EXPONENT INC
149 Commonwealth Drive, Exponent Inc
Menlo Park CALIFORNIA 94025 US
CEO: Catherine Ford Corrigan
Employees: 1168
Company Website: https://www.exponent.com/
Investor Relations: https://www.exponent.com/investors
Phone: 16503269400
EXPONENT INC / EXPO FAQ
What is the stock price of EXPONENT INC today?
The current stock price of EXPO is 77.82 USD. The price decreased by -1.09% in the last trading session.
What is the ticker symbol for EXPONENT INC stock?
The exchange symbol of EXPONENT INC is EXPO and it is listed on the Nasdaq exchange.
On which exchange is EXPO stock listed?
EXPO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for EXPONENT INC stock?
9 analysts have analysed EXPO and the average price target is 110.16 USD. This implies a price increase of 41.56% is expected in the next year compared to the current price of 77.82. Check the EXPONENT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EXPONENT INC worth?
EXPONENT INC (EXPO) has a market capitalization of 3.95B USD. This makes EXPO a Mid Cap stock.
How many employees does EXPONENT INC have?
EXPONENT INC (EXPO) currently has 1168 employees.
What are the support and resistance levels for EXPONENT INC (EXPO) stock?
EXPONENT INC (EXPO) has a support level at 77.76 and a resistance level at 80.98. Check the full technical report for a detailed analysis of EXPO support and resistance levels.
Is EXPONENT INC (EXPO) expected to grow?
The Revenue of EXPONENT INC (EXPO) is expected to grow by 3.55% in the next year. Check the estimates tab for more information on the EXPO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EXPONENT INC (EXPO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EXPO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EXPO, evaluating the profitability, health, valuation and growth aspects
- EXPONENT INC (EXPO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EXPONENT INC (EXPO) Sales and EPS estimates to see what analysts future expectations are.
- EXPONENT INC (EXPO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EXPONENT INC (EXPO) Insider and Institutional Ownership to learn about the owners and their transactions.
- EXPONENT INC (EXPO) Stock Chart to make your own analysis
- EXPONENT INC (EXPO) Latest news and press-releases to stay up to date.
Does EXPONENT INC (EXPO) stock pay dividends?
EXPONENT INC (EXPO) has a dividend yield of 1.53%. The yearly dividend amount is currently 1.07. Check the full fundamental report for a detailed analysis of EXPO dividend history, reliability and sustainability.
When does EXPONENT INC (EXPO) report earnings?
EXPONENT INC (EXPO) will report earnings on 2025-07-23, after the market close.
What is the Price/Earnings (PE) ratio of EXPONENT INC (EXPO)?
The PE ratio for EXPONENT INC (EXPO) is 37.96. This is based on the reported non-GAAP earnings per share of 2.05 and the current share price of 77.82 USD. Check the full fundamental report for a full analysis of the valuation metrics for EXPO.
What is the Short Interest ratio of EXPONENT INC (EXPO) stock?
The outstanding short interest for EXPONENT INC (EXPO) is 3.46% of its float. Check the ownership tab for more information on the EXPO short interest.
EXPO Technical Analysis
EXPO Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to EXPO. EXPO gets an excellent profitability rating and is at the same time showing great financial health properties.
EXPO Financial Highlights
Over the last trailing twelve months EXPO reported a non-GAAP Earnings per Share(EPS) of 2.05. The EPS increased by 3.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.52% | ||
| ROA | 14.02% | ||
| ROE | 25.89% | ||
| Debt/Equity | 0 |
EXPO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to EXPO. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -4.58% and a revenue growth 3.55% for EXPO